Genotypes | BLL1a (n = 190) | BLL2b (n = 114) |
P
c
| Crude OR (95% CI) | Adjusted OR (95% CI)d |
---|
N | % | N | % |
---|
rs7079 |
CC | 100 | 52.6 | 76 | 66.7 | 0.04 | 1.00 | 1.00 |
CA | 88 | 46.3 | 36 | 31.6 | 1.86 (1.14–3.03) | 2.27 (1.33–3.86) |
AA | 2 | 1.1 | 2 | 1.7 | 0.76 (0.11–5.52) | 0.93 (0.12–7.31) |
CA + AA | 90 | 47.4 | 38 | 33.3 | 0.02 | 1.80 (1.11–2.92) | 1.92 (1.16–3.18) |
A Allele | 92 | 24.2 | 92 | 17.5 | 0.08 | | |
- The observed genotype frequency among the control subjects was in agreement with Hardy-Weinberg equilibrium (p2 + 2pq + q2 = 1) (χ2 = 0.954, P = 0.329 for rs7079
- a Blood lead level (BLL) < 200 μg/L
- b Blood lead level (BLL) ≥ 400 μg/L
- c Two-sided χ2 test for either genotype or allele frequency
- d Obtained from logistic regression models adjusted for age, sex, and smoking habits